New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
16:11 EDTQDELQuidel reports Q4 EPS 37c, may not compare to consensus 17c
Reports Q4 revenue $53.9M, consensus $53.26M. The company said its increase in revenue was driven by growth of infectious disease products in the quarter, due to the onset of an early and severe influenza and respiratory disease season. Quidel reported Q4 GAAP EPS of 26c, which may compare to consensus.
News For QDEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 15, 2014
14:01 EDTQDELQuidel receives FDA clearance for Lyra molecular PCR assay
Subscribe for More Information
October 13, 2014
14:01 EDTQDELQuidel receives FDA clearance for Lyra molecular PCR assay
Quidel announced that it has received 510k clearance from the FDA to market its Lyra Adenovirus Assay, a real-time PCR test for the qualitative detection of human adenovirus viral DNA isolated from nasal swab and nasopharyngeal swab specimens. Adenovirus outbreaks can occur throughout the year, but are more common from late winter to early summer. Quidel's Lyra Adenovirus Assay is part of the new Lyra brand of ready-to-use, molecular PCR reagent kits specifically designed to be compatible with a laboratory's existing thermocycler.
10:59 EDTQDELEbola in U.S. could boost flu testing, says Piper Jaffray
Piper Jaffray believes the emergence of Ebola cases in the U.S. could drive incremental flu testing since the disease shares some initial symptoms with flu, likely driving people to get a test. Piper says it has increased confidence in its flu upside scenario for Quidel. It has an Overweight rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use